Business Context and Reporting Period
This Form 8-K is a current report filed by MicroVision, Inc. on August 7, 2026. The filing discloses the appointment of a new Chief Financial Officer (CFO) and the transition of the interim CFO. The company is incorporated in Delaware and its common stock trades on The NASDAQ Stock Market under the symbol MVIS.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive personnel changes and associated compensation arrangements.
Material Changes
The primary material change reported is the leadership transition within the finance function:
- Appointment: Christine Chambers was appointed as Chief Financial Officer, effective August 27, 2026.
- Departure: Stephen Hrynewich will cease serving as Interim Chief Financial Officer on the effective date but will remain in a senior finance role. The transition is not due to any disagreement regarding operations or policies.
Compensation and Management Commentary
The Compensation Committee approved the following compensatory arrangements for Ms. Chambers:
- Base Salary: $425,000 annually.
- Annual Incentive Bonus: Targeted at 65% of base salary, payable in cash or vested RSUs.
- New-Hire Equity: One-time RSU award valued at $1,000,000 on the grant date, vesting over four years.
- Long-Term Equity: Annual RSU opportunity valued at $800,000 on the grant date, vesting in three equal installments.
- Severance: Eligible for the Key Executive Severance and Change in Control Plan (Tier 2) effective three months after her start date.
Risks and Contingencies: The filing states there are no arrangements or understandings with third parties regarding the appointment and no family relationships between Ms. Chambers and existing directors or officers.
Investor Verification Checklist
- Verify the effective start date of August 27, 2026, for the new CFO.
- Confirm the total value of the initial equity grant ($1,000,000) and the vesting schedule.
- Review the company's upcoming 10-Q or 10-K filings to assess the impact of this leadership change on financial reporting and strategy.
- Check for any subsequent filings regarding the specific equity incentive plan under which the RSUs were granted.